Safety Reading Notes

Read safety context beside the research guide.

The SEA source set includes safety-context rows around SEA biology, metabolism, physiology, or safety-relevant mechanisms: preclinical. Public reading should keep these rows beside the benefit-oriented buckets, because product identity, dose, route, population, impairment, interactions, and adverse-event context can change what a study means. PMID 31881191

Evidence class: preclinical

PubMed For Dummies Article

SEA Evidence Review: the long-form source walk-through

Quick read
  • SEA currently has 16 source-backed evidence row(s), so this page should be read as a research guide rather than a single conclusion. PMID 31881191
  • The evidence classes most visible in the row language are preclinical (6), mechanistic or pharmacological (5), insufficient (4), and preliminary human (1). PMID 20353771
  • The study-design language most visible in the row language is Animal study (7), and Narrative or expert review (4). PMID 24874648
  • The repeated topics are SEA biology, metabolism, physiology, or safety-relevant mechanisms (16), which tells the reader where to start opening PubMed and DOI links. PMID 12010121

Start with the research question

SEA is built from 16 source-backed evidence row(s) and 16 research source(s). The current evidence classes read as preclinical (6), mechanistic or pharmacological (5), insufficient (4), and preliminary human (1), and the study-design language most often reads as Animal study (7), and Narrative or expert review (4). PMID 31881191

The row-level question is not simply whether SEA is "good" or "bad." The useful question is what each row studied, what evidence class it received, and whether the source is close to the reader's actual question. The most repeated row topics are SEA biology, metabolism, physiology, or safety-relevant mechanisms (16). PMID 12010121

Human evidence 1 row

Rows involving human participants, patients, or clinical source language. These rows are closer to everyday reader questions, but still depend on population, dose, route, comparator, and endpoint. PMID 22125609

Preclinical evidence 6 rows

Animal, cellular, or model-based rows. These can explain why a topic is being studied, but they should not be read as human-health instructions. PMID 23707281

Mechanistic evidence 5 rows

Rows about receptors, enzymes, channels, metabolism, binding, signaling, or pharmacology. These explain plausibility without proving a consumer outcome. PMID 37578507

Limits and uncertainty 4 rows

Rows where safety, tolerability, risk, product limits, or insufficient evidence need to stay visible next to the rest of the article. PMID 27531672

The lane labels are not a quality score. They are a reading method: keep human evidence, preclinical evidence, mechanisms, and uncertainty in separate mental boxes before deciding what a source can actually support. PMID 38279735

Where this page has the most source density

The largest bucket surfaced for this page is SEA biology, metabolism, physiology, or safety-relevant mechanisms: preclinical. That does not automatically mean the topic is settled; it means this is where the current source trail is densest. The next visible bucket is SEA biology, metabolism, physiology, or safety-relevant mechanisms: mechanistic or pharmacological, which gives readers another way to see what the literature repeatedly circles. PMID 31881191

Source density should be read with evidence posture. A bucket can contain many rows and still be limited if the studies are indirect, mixed, preclinical, product-specific, or mostly review-level. The paragraphs below name the buckets directly and keep each explanation connected to a source record. PMID 12010121

Bucket chapters: what the literature is circling

SEA biology, metabolism, physiology, or safety-relevant mechanisms: preclinical

6 research sources 6 rows (1187, 1194, 1196, 1198, 1199, 1201) Evidence class: preclinical

This bucket summarizes source-backed rows focused on SEA biology, metabolism, physiology, or safety-relevant mechanisms: preclinical. It currently draws from 6 research source(s), so the exact study type matters. PMID 31881191

Read this bucket as safety context first. It belongs beside any benefit-oriented rows because risk, route, dose, product quality, co-exposures, and population can change what a source means. PMID 31881191

  • Evidence row 1187

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preclinical (population or model: Animal model mentioned; study design: Animal study; outcome measure: SEA biology, metabolism,... PMID 31881191

  • Evidence row 1194

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preclinical (population or model: Human participants or patients mentioned; study design: Animal study; outcome measure: SEA bi... PMID 38279735

SEA biology, metabolism, physiology, or safety-relevant mechanisms: mechanistic or pharmacological

5 research sources 5 rows (1189, 1190, 1191, 1193, 1200) Evidence class: mechanistic or pharmacological

This bucket summarizes source-backed rows focused on SEA biology, metabolism, physiology, or safety-relevant mechanisms: mechanistic or pharmacological. It currently draws from 5 research source(s), so the exact study type matters. PMID 12010121

Read this bucket as safety context first. It belongs beside any benefit-oriented rows because risk, route, dose, product quality, co-exposures, and population can change what a source means. PMID 12010121

  • Evidence row 1189

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: mechanistic or pharmacological (population or model: Human participants or patients mentioned; study design: Animal study; outc... PMID 12010121

  • Evidence row 1190

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: mechanistic or pharmacological (population or model: Human participants or patients mentioned; outcome measure: SEA biology, me... PMID 22125609

SEA biology, metabolism, physiology, or safety-relevant mechanisms: insufficient

4 research sources 4 rows (1186, 1188, 1195, 1197) Evidence class: insufficient

This bucket summarizes source-backed rows focused on SEA biology, metabolism, physiology, or safety-relevant mechanisms: insufficient. It currently draws from 4 research source(s), so the exact study type matters. PMID 20353771

Read this bucket as safety context first. It belongs beside any benefit-oriented rows because risk, route, dose, product quality, co-exposures, and population can change what a source means. PMID 20353771

  • Evidence row 1186

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: insufficient (population or model: Animal model mentioned; study design: Narrative or expert review; outcome measure: SEA biolo... PMID 20353771

  • Evidence row 1188

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: insufficient (population or model: Cellular or in vitro model mentioned; study design: Narrative or expert review; outcome meas... PMID 24874648

SEA biology, metabolism, physiology, or safety-relevant mechanisms: preliminary human

1 research source 1192 Evidence class: preliminary human

This bucket summarizes source-backed rows focused on SEA biology, metabolism, physiology, or safety-relevant mechanisms: preliminary human. It currently draws from 1 research source(s), so the exact study type matters. PMID 37578507

Read this bucket as safety context first. It belongs beside any benefit-oriented rows because risk, route, dose, product quality, co-exposures, and population can change what a source means. PMID 37578507

  • Evidence row 1192

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preliminary human (population or model: Human participants or patients mentioned; outcome measure: SEA biology, metabolism, phy... PMID 37578507

Human evidence, mechanisms, and safety are different lanes

This page currently separates human evidence (1 row(s)), mechanistic evidence (5 row(s)), and safety/tolerability context (0 row(s)). That separation is the heart of the site. Mechanistic evidence can make a topic biologically interesting, but it should not silently become a human outcome. PMID 31881191

Human evidence still depends on population, dose, route, duration, product identity, and endpoint. Safety rows belong in the same reading path as benefit-oriented rows because formulation, co-exposures, prescription medications, impairment context, and higher-risk populations can change how close a source is to a reader's question. PMID 12010121

What this does and does not mean

  • It means the page has a traceable source trail. It does not mean every bucket has the same clinical strength. PMID 26839710
  • It means mechanisms, animal models, human studies, safety rows, and insufficient-evidence rows are being kept visible as separate evidence types. PMID 25566671
  • It does not turn a preclinical mechanism into a consumer recommendation, and it does not treat one product, dose, route, or population as interchangeable with another. PMID 23813098

How to use the source table

The source-backed evidence table below is the audit trail. Each row keeps a public sentence connected to a source record when a PubMed ID or DOI is available. If a sentence feels important, the reader should be able to click through, inspect the study type, and decide whether the source is close to the question they care about. PMID 31881191

This is why the public page is intentionally layered. The top gives the reader a fast orientation. The bucket table groups repeated rows into readable topics. The article body explains the buckets using the actual evidence-row language. The source notes below walk through every evidence row before the source table repeats the technical trace. PMID 12010121

Source-reading checklist for SEA

  1. Open the linked PubMed or DOI record. PMID 18710028
  2. Check whether the source studied humans, animals, cells, chemistry, pharmacology, product testing, or a review of prior literature. PMID 19873884
  3. Compare the source product, dose, route, population, and endpoint to the question being asked. PMID 16154384
  4. Look for safety, tolerability, drug-interaction, impairment, pregnancy, pediatric, psychiatric, cardiovascular, and product-quality context before treating the bucket as settled. PMID 33434116
  5. Return to the evidence table when the article summary sounds too broad; the row is the audit unit. PMID 31881191

Source Notes

SEA source-by-source reading notes

These notes pull every evidence row on this page into the readable article body before the source table repeats the audit trail. Each note keeps the row language beside the PubMed or DOI link when available.

  1. Evidence row 1186

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: insufficient (population or model: Animal model mentioned; study design: Narrative or expert review; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 20353771

    Evidence class: insufficient; Study design: Narrative or expert review. Source: Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.
  2. Evidence row 1187

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preclinical (population or model: Animal model mentioned; study design: Animal study; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 31881191

    Evidence class: preclinical; Study design: Animal study. Source: Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation.
  3. Evidence row 1188

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: insufficient (population or model: Cellular or in vitro model mentioned; study design: Narrative or expert review; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 24874648

    Evidence class: insufficient; Study design: Narrative or expert review. Source: Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury.
  4. Evidence row 1189

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: mechanistic or pharmacological (population or model: Human participants or patients mentioned; study design: Animal study; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 12010121

    Evidence class: mechanistic or pharmacological; Study design: Animal study. Source: Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells.
  5. Evidence row 1190

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: mechanistic or pharmacological (population or model: Human participants or patients mentioned; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 22125609

    Evidence class: mechanistic or pharmacological. Source: High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women.
  6. Evidence row 1191

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: mechanistic or pharmacological (outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 23707281

    Evidence class: mechanistic or pharmacological. Source: Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity.
  7. Evidence row 1192

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preliminary human (population or model: Human participants or patients mentioned; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 37578507

    Evidence class: preliminary human. Source: Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy Study.
  8. Evidence row 1193

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: mechanistic or pharmacological (outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 27531672

    Evidence class: mechanistic or pharmacological. Source: High levels of endogenous lipid mediators (N-acylethanolamines) in women with chronic widespread pain during acute tissue trauma.
  9. Evidence row 1194

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preclinical (population or model: Human participants or patients mentioned; study design: Animal study; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 38279735

    Evidence class: preclinical; Study design: Animal study. Source: N-Stearoylethanolamine Exerts Cardioprotective Effects in Old Rats.
  10. Evidence row 1195

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: insufficient (study design: Narrative or expert review; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 26839710

    Evidence class: insufficient; Study design: Narrative or expert review. Source: Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification.
  11. Evidence row 1196

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preclinical (population or model: Animal model mentioned; study design: Animal study; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 25566671

    Evidence class: preclinical; Study design: Animal study. Source: [Effects of N-stearoylethanolamine on the emotionality and learning ability of rats].
  12. Evidence row 1197

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: insufficient (population or model: Animal model mentioned; study design: Narrative or expert review; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 23813098

    Evidence class: insufficient; Study design: Narrative or expert review. Source: Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
  13. Evidence row 1198

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preclinical (population or model: Animal model mentioned; study design: Animal study; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 18710028

    Evidence class: preclinical; Study design: Animal study. Source: [Immunosuppressive characteristics of N-stearoylethanolamine a stable compound with cannabimimetic activity].
  14. Evidence row 1199

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preclinical (population or model: Animal model mentioned; study design: Animal study; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 19873884

    Evidence class: preclinical; Study design: Animal study. Source: [Anti-inflammatory effect of N-stearoylethanolamine in experimental burn injury in rats].
  15. Evidence row 1200

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: mechanistic or pharmacological (population or model: Animal model mentioned; study design: Animal study; outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 16154384

    Evidence class: mechanistic or pharmacological; Study design: Animal study. Source: Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
  16. Evidence row 1201

    SEA studied for SEA biology, metabolism, physiology, or safety-relevant mechanisms; evidence class: preclinical (outcome measure: SEA biology, metabolism, physiology, or safety-relevant mechanisms). PMID 33434116

    Evidence class: preclinical. Source: Exploring the Utility of Hair Endocannabinoids for Monitoring Homeostasis in Bonobos.